BeiGene Appoints Julius Pryor III as First Global Head of Diversity and Health Equity
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the appointment of Julius Pryor III as its first Global Head of Diversity and Health Equity, effective immediately.
- BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the appointment of Julius Pryor III as its first Global Head of Diversity and Health Equity, effective immediately.
- “As a global company determined to deliver accessible and affordable medicines to more patients around the world, health equity and diversity are central values for BeiGene,” said Graham Hardiman, Head of Global Human Resources at BeiGene.
- Mr. Pryor joins BeiGene from the J. Pryor Group, where he served as a General Managing Partner.
- He was Vice President of Global Diversity at both J&J and CCE, and served as Head of Innovation, Diversity & Inclusion at Genentech.